PL3348273T3 - Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych - Google Patents

Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych

Info

Publication number
PL3348273T3
PL3348273T3 PL18157960T PL18157960T PL3348273T3 PL 3348273 T3 PL3348273 T3 PL 3348273T3 PL 18157960 T PL18157960 T PL 18157960T PL 18157960 T PL18157960 T PL 18157960T PL 3348273 T3 PL3348273 T3 PL 3348273T3
Authority
PL
Poland
Prior art keywords
xyloglucan
proteins
treatment
compositions based
intestinal disorders
Prior art date
Application number
PL18157960T
Other languages
English (en)
Inventor
Miguel Angel Alonso Cohen
Michele Giuseppe Di Schiena
Marco Di Fulvio
Original Assignee
Devintec, Sagl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devintec, Sagl filed Critical Devintec, Sagl
Publication of PL3348273T3 publication Critical patent/PL3348273T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18157960T 2014-04-15 2015-04-15 Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych PL3348273T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI20140705 2014-04-15
EP15719637.9A EP3131568B1 (en) 2014-04-15 2015-04-15 Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
PCT/EP2015/058162 WO2015158771A1 (en) 2014-04-15 2015-04-15 Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
EP18157960.8A EP3348273B8 (en) 2014-04-15 2015-04-15 Compositions based on xyloglucan and proteins for the treatment of intestinal disorders

Publications (1)

Publication Number Publication Date
PL3348273T3 true PL3348273T3 (pl) 2020-03-31

Family

ID=50897780

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18157960T PL3348273T3 (pl) 2014-04-15 2015-04-15 Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych

Country Status (6)

Country Link
US (3) US20170027980A1 (pl)
EP (2) EP3131568B1 (pl)
CA (1) CA2945631C (pl)
ES (2) ES2675305T3 (pl)
PL (1) PL3348273T3 (pl)
WO (1) WO2015158771A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2675305T3 (es) * 2014-04-15 2018-07-10 Novintethical Pharma Sa Composiciones a base de xiloglucano y proteínas para el tratamiento de trastornos intestinales
CA3023797A1 (en) 2016-05-31 2017-12-07 Novintethical Pharma Sa Compositions for the treatment of intestinal disorders
JP7822689B2 (ja) * 2016-07-13 2026-03-03 ディーエスエム・ニュートリショナル・プロダクツ・エルエルシー グリカン組成物および使用方法
IT201800006400A1 (it) * 2018-06-18 2019-12-18 Composizione per le patologie gastriche ed esofagee
GR1009632B (el) * 2018-07-09 2019-10-25 Ιουλια Κλεωνος Τσετη Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος
CA3111353A1 (en) 2018-09-06 2020-03-12 Fachhochschule Nordwestschweiz Controlled drug release formulation
IT201900025246A1 (it) * 2019-12-23 2021-06-23 Devintec Sagl Composizioni topiche comprendenti proteine vegetali e polifenoli
TWI840668B (zh) * 2021-05-13 2024-05-01 陳昭誠 由β-1-4-葡聚醣形成之纖維於製備用於治療腸躁症之組成物之用途
IT202300004341A1 (it) * 2023-03-08 2024-09-08 Devintec Sagl Composizione orale a base di principi attivi di origine naturale e suo uso in terapia e nel trattamento e nella prevenzione delle affezioni della mucosa orale

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515667A (en) * 1966-12-12 1970-06-02 Universal Oil Prod Co Drilling fluid additive
US4070488A (en) * 1975-11-25 1978-01-24 Davis Rachel D Nutritive composition
JPS5939363B2 (ja) * 1978-02-24 1984-09-22 克彦 谷 食塩製造方法
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
US5262315A (en) * 1990-04-19 1993-11-16 Pernod Ricard Production of vanillin by bioconversion of benzenoid precursors by pyenoporus
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
IT1283911B1 (it) 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6387210B1 (en) * 1998-09-30 2002-05-14 Kimberly-Clark Worldwide, Inc. Method of making sanitary paper product from coarse fibers
DE60117971T2 (de) * 2000-05-12 2006-10-12 Bengt Krister Olson Zusammensetzungen mit kombinierten extrakten aus knorpelgewebe und pflanzen
US6811243B2 (en) * 2001-10-05 2004-11-02 E. I. Du Pont De Nemours And Company Priming fluid for ink jet printheads
EP1718280A4 (en) * 2004-01-30 2010-08-18 Mars Inc METHOD AND COMPOSITIONS FOR CANCER TREATMENT
ITBO20050388A1 (it) * 2005-06-06 2006-12-07 Alfa Wassermann Spa Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
EP1764105A1 (de) 2005-09-20 2007-03-21 Rentschler Arzneimittel GmbH Verwendung von Gerbstoffen zur Behandlung der Chemotherapie induzierten Diarrhoe
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
AU2008273699A1 (en) * 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions of rifaximin
US20090062191A1 (en) 2007-08-29 2009-03-05 Kiel Laboratories, Inc. Composition for maintaining gastrointestinal homeostasis
ITRM20070510A1 (it) 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
EP2361623A1 (en) 2010-02-09 2011-08-31 Novintethical Pharma, SAGL Composition comprising a polyphenol salt and corresponding use
WO2011147767A1 (en) 2010-05-24 2011-12-01 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of microbial infections
AU2011257388B2 (en) 2010-05-24 2016-10-13 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
ITMI20110934A1 (it) 2011-05-24 2012-11-25 Cohen Miguel Angel Alonso Tannato di gelatina e sue associazioni per uso nel trattamento di malattie infiammatorie gastrointestinali
ITMI20121328A1 (it) * 2012-07-30 2014-01-31 Probiotical Spa Composizione per dispositivo medico comprendente ceppi di batteri produttori di esopolisaccaridi in associazione con gomme e/o gelatine.
ES2675305T3 (es) * 2014-04-15 2018-07-10 Novintethical Pharma Sa Composiciones a base de xiloglucano y proteínas para el tratamiento de trastornos intestinales

Also Published As

Publication number Publication date
EP3348273A1 (en) 2018-07-18
US20170252366A1 (en) 2017-09-07
US20180318333A1 (en) 2018-11-08
US20170027980A1 (en) 2017-02-02
US10758561B2 (en) 2020-09-01
EP3131568A1 (en) 2017-02-22
CA2945631C (en) 2023-04-11
EP3348273B1 (en) 2019-07-31
ES2750152T3 (es) 2020-03-25
WO2015158771A1 (en) 2015-10-22
EP3348273B8 (en) 2019-09-18
ES2675305T3 (es) 2018-07-10
EP3131568B1 (en) 2018-06-06
CA2945631A1 (en) 2015-10-22
US10064886B2 (en) 2018-09-04

Similar Documents

Publication Publication Date Title
ZA201901279B (en) Compositions and methods for treatment of neurological disorders
DK3889145T3 (da) 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme
LT3224269T (lt) Kompozicijos ir būdai, skirti cns sutrikimams gydyti
IL255109A0 (en) New dihydropyridoisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
IL260352B (en) Methods and preparations for the treatment of neurological disease
LT3206497T (lt) Kompozicijos ir būdai, skirti meibomo liaukos disfunkcijos gydymui
LT3250210T (lt) Kompozicijos ir būdai, skirti gydyti cns sutrikimus
IL266047A (en) Methods and preparations for the treatment of Fabry disease
GB201402070D0 (en) Pharmaceutical compositions for the treatment of inflammatory disorders
EP3104706A4 (en) Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
EP3183005A4 (en) Methods and compositions for the treatment of metabolic disorders
EP3348273B8 (en) Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
IL258032A (en) Compounds and preparations for the treatment of ocular disorders
HUE049518T2 (hu) Készítmények és eljárások a szem megbetegedéseinek kezelésére és diagnosztizálására
SMT202100373T1 (it) Metodi e composizioni per la stimolazione del sistema enteroendocrino intestinale per il trattamento di malattie o condizioni correlate allo stesso
SG11201609993YA (en) Treatment of immune disorders
GB201401086D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
SG11201702554QA (en) Compositions and methods for the treatment of multiple sclerosis
SG11201708181RA (en) Methods for the treatment of inflammatory disorders
EP3258930A4 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
GB201607388D0 (en) Treatment of impulsivity-related disorders
EP3107534A4 (en) Compositions and methods for the treatment of neurodegenerative diseases
EP3096775A4 (en) Socs mimetics for the treatment of diseases